Latest News

In February, an amendment to the infant formulae and follow-on formulae regulation came into effect. This amendment permits goats’ milk infant formula and follow-on formula to be sold on the UK market. At this time, the Food Standards Agency expects

Statement regarding recent study linking commonly used medicines, including over-the-counter anticholinergic antihistamine treatments for conditions such as hay-fever, to dementia. A recent study found there may be a link between commonly used medicines, including some first-generation antihistamines, and dementia. The BBC

Last week The FSA  issued an alert to people with nut allergies about a batch of ground cumin sold by The Barts Ingredients Company Ltd which was found to contain traces of almond protein not listed on the label. The

Summary In the UK, 40-50% of children have at least one diagnosed allergy. The increased prevalence of allergies negatively impacts affected children’s quality of life and puts pressure on health services. This 'Postnote' discusses the causes and extent of allergic

The Anaphylaxis Campaign has become a member of the Specialised Healthcare Alliance (SHCA), the group campaigning on behalf of people with rare and complex conditions. The Alliance is a coalition of 100 patient-related organisations, supported by 14 corporate members, all

Every year, around 62,000 people in England have a serious allergic reaction to a drug which puts them in hospital. NICE has published its first guideline on drug allergy in adults, children and young people, which aims to dispel confusion

The event held at Governors’ Hall, St Thomas’ Hospital highlighted the Charity’s achievements over the last 20 years and honoured instrumental figures in accomplishing important milestones, such as changes to food labelling and the establishment of many of the UK’s

The Prescription Charges Coalition has issued a statement in response to proposals from the Barker Commission which recommend some fundamental changes to prescription charges in order to raise a potential additional £1 billion revenue for the NHS. These include the